We therefore inferred a recovery of the T-cell repertoire in these patients after biologic therapy based on our observation and results from previous studies showing that CD4+ T-cell repertoire diversity in RA patients was reduced compared with healthy individuals and was increased after treatment [31–34]. The gene discussed is CD4; the disease is rheumatoid arthritis.